BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31552613)

  • 21. The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer.
    Zhang H; Zhao YC; Wu Q; Wang L; Sun S
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):498-507. PubMed ID: 33864292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.
    Prassas D; Kounnamas A; Cupisti K; Schott M; Knoefel WT; Krieg A
    Ann Surg Oncol; 2022 Apr; 29(4):2561-2569. PubMed ID: 34890024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
    Torresan F; Mian C; Cavedon E; Iacobone M
    Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
    Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
    J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
    Meng K; Luo H; Chen H; Guo H; Xia W
    Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
    Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
    Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.
    He X; Wu W; Lin Z; Ding Y; Si J; Sun LM
    Gastric Cancer; 2018 May; 21(3):391-400. PubMed ID: 29052053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.
    Wang J; Dang P; Raut CP; Pandalai PK; Maduekwe UN; Rattner DW; Lauwers GY; Yoon SS
    Ann Surg; 2012 Mar; 255(3):478-85. PubMed ID: 22330040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.
    Moeckelmann N; Ebrahimi A; Tou YK; Gupta R; Low TH; Ashford B; Ch'ng S; Palme CE; Clark JR
    Oral Oncol; 2018 Oct; 85():82-86. PubMed ID: 30220324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.